Amarillo Biosciences Inc (OTCMKTS:AMAR) Director David Kanen bought 265,000 shares of the firm’s stock in a transaction on Friday, September 13th. The shares were acquired at an average price of $1.67 per share, for a total transaction of $442,550.00.
Shares of OTCMKTS:AMAR traded up $0.03 on Tuesday, reaching $0.44. 2,000 shares of the company’s stock were exchanged, compared to its average volume of 1,310. The company has a fifty day moving average of $0.40 and a 200-day moving average of $0.36. Amarillo Biosciences Inc has a twelve month low of $0.12 and a twelve month high of $0.61.
About Amarillo Biosciences
Featured Story: What does the Dow Jones Industrial Average (DJIA) measure?
Receive News & Ratings for Amarillo Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amarillo Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.